Royal Marsden NHS Foundation Trust
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Surgical Anatomy and 'Waisting' of the sIgmoid SpEcimen
- Conditions
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 20
- Registration Number
- NCT03135808
- Locations
- 🇬🇧
Royal Marsden Hospital, London, United Kingdom
Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma
- First Posted Date
- 2017-04-21
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 24
- Registration Number
- NCT03123276
- Locations
- 🇬🇧
Royal Marsden, London, United Kingdom
Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 300
- Registration Number
- NCT03072316
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing
- Conditions
- First Posted Date
- 2017-01-20
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 285
- Registration Number
- NCT03026751
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 49
- Registration Number
- NCT03010722
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust London and Surrey, Carshalton, Surrey, United Kingdom
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
- Conditions
- Interventions
- First Posted Date
- 2016-12-20
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 34
- Registration Number
- NCT02998567
- Locations
- 🇬🇧
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
🇬🇧UCLH, London, United Kingdom
PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer
- First Posted Date
- 2016-12-16
- Last Posted Date
- 2016-12-19
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 47
- Registration Number
- NCT02994888
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Surrey, Sutton, United Kingdom
A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy
- First Posted Date
- 2016-11-30
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 245
- Registration Number
- NCT02978014
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
🇬🇧Cambridge University Hospitals, Cambridge, United Kingdom
🇬🇧Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
- First Posted Date
- 2016-08-31
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 17
- Registration Number
- NCT02884453
- Locations
- 🇬🇧
The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Interventions
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 3
- Registration Number
- NCT02819752
- Locations
- 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom